Last updated: July 11, 2026

Application No. 19/222,947

Untitled Application

Unknown

Filed

1600

Priority

Apr 24, 2024 — provisional 63/638,348 +1 more

Examiner

SEAMAN, D MARGARET M

Art Unit

1625

Tech Center

Veradermics, Incorporated

Assignee

VERADERMICS INCORPORATED

OA Round

1 (Non-Final)

Interview Optional

— +8.0% interview lift. Interview lift (+8.0%) is below the 15.0% threshold. A written response is recommended.

Based on 1394 resolved cases, 2023–2026

Examiner Intelligence

SEAMAN, D MARGARET M View full profile →

Grants 77% — above average

Career Allowance Rate

1068 granted / 1394 resolved

+16.6% vs TC avg

Moderate +8% lift

Without

With

+8.0%

Interview Lift

resolved cases with interview

Fast prosecutor

2y 2m

Avg Prosecution

37 currently pending

Career history

1417

Total Applications

across all art units

Statute-Specific Performance

§101

1.6%

-38.4% vs TC avg

§103

20.3%

-19.7% vs TC avg

§102

16.9%

-23.1% vs TC avg

§112

30.8%

-9.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1394 resolved cases

Prosecution Timeline

1600

Application Filed

Feb 03, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/589,118

Patent 12673919

PROCESS FOR PREPARING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANOIC ACIDS, ESTERS AND AMIDES

4y 5m to grant Granted Jul 07, 2026

18/273,502

Patent 12668575

N-(BENZOYL)-PHENYLALANINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF

2y 11m to grant Granted Jun 30, 2026

18/264,986

Patent 12662497

BENZAZEPINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

2y 10m to grant Granted Jun 23, 2026

18/166,235

Patent 12655112

CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND

3y 4m to grant Granted Jun 16, 2026

18/267,331

Patent 12649726

A Substituted Tetrahydroisoquinoline Derivative As A D1 Positive Allosteric Modulator

2y 12m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

77%

Grant Probability

85%

With Interview (+8.0%)

2y 2m

Median Time to Grant

Low

PTA Risk

Based on 1394 resolved cases by this examiner. Grant probability derived from career allowance rate.